Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di S Regulatory News (MYXR)

  • There is currently no data for MYXR

Directorate Changes

29 Jul 2019 07:00

RNS Number : 9156G
MyCelx Technologies Corporation
29 July 2019
 

29 July 2019

MYCELX TECHNOLOGIES CORPORATION

("MYCELX" or the "Company")

Directorate Changes

 

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for the Oil and Gas market and commercial industrial markets worldwide, is pleased to announce the appointment of Tom Lamb as a Non-Executive Director, and Chairman of the Compensation Committee and a member of the Audit and Nomination Committees, with effect 29 July 2019.

Tom has a wealth of strategic and operating expertise in the industrial and technology sectors, having spent over 30 years driving organic growth and leading businesses in multiple international settings. He has served in several executive leadership roles in public and private companies; and is currently CEO of TWR/Pharos-API, a navigational equipment company focused on the Oil & Gas and other markets. His previous experience includes Chairman & CEO of Agilex Flavors and Fragrances, President and CEO of C.P.Kelco/J.M. Huber Corporation and Executive VP of Lexmark International. Tom has also served on the boards of several for-profit companies in chemical, technology and healthcare spaces.

Brian Rochester, who has acted as a Non-Executive Director and as Chairman of the Compensation Committee of the Company since 1998, will step down from this role following Mr Lamb's appointment.

Commenting on today's announcement Tim Eggar, Chairman of MYCELX, said:

"I would like to welcome Tom onto the Board. He brings considerable expertise to our team and we look forward to his contribution in his role as Chairman of the Compensation Committee and in assisting the Company's continuing growth and development.

On behalf of the Board, I would also like to express our gratitude to Brian for his long-standing contribution to the Company, both as a Non-Executive Director and as Chairman of the Compensation Committee."

There is no information that is required to be disclosed with regards to the appointment of Thomas Barton Lamb, aged 61, pursuant to Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules, save as set out below:

 

Current directorships and partnerships

 

TWR/Pharos-API

 

Directorships and partnerships held within the past five years

 

Illuma Inc.

AG Triada Holding Inc

Evo-Shield, LLC

All About Developmental Disabilities

Nicholas House for Homeless Families

Lamb Operating Advisors LLC

 

Mr Lamb was a Director of Baseball Protective, LLC (also known as EvoShield, LLC), a manufacturer and distributor of sporting goods in Georgia, USA, which entered involuntary bankruptcy on 29 September 2017.

Shareholding in the Company

Nil

 

For further information please contact:

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

Tel: +1 888 306 6843

Numis Securities (Nomad and Broker)

John Prior

Alamgir Ahmed

James Black

Emily Morris

 

 

Tel: +44 20 7894 7000

Celicourt Communications

Mark Antelme

Jimmy Lea

 

Tel: +44 20 8434 2754

Notes to Editors

MYCELX is a revolutionary oil-free water technology company solving the world's toughest oil removal problems in the oil and gas industry. The systems are based upon scientific breakthrough for a completely different approach to permanent oil removal. The Company created the patented MYCELX polymer using innovative molecular cohesion for removing oil from water far beyond what conventional systems have ever achieved. MYCELX systems remove oil to critically low levels in a much smaller physical footprint than conventional systems and in a virtually fail-safe process.

www.mycelx.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKMGZNFVRGLZM
Date   Source Headline
14th Mar 20234:50 pmRNSClosure of Restricted Stock Line
13th Feb 20237:00 amRNSOperational Update
31st Jan 20237:00 amRNSTrading Update
8th Dec 20227:00 amRNSTrading Update
27th Sep 20227:00 amRNSHalf Year Results Statement
15th Sep 20227:00 amRNSTrading Update
6th Sep 20222:30 pmRNSHolding(s) in Company
30th Aug 20227:00 amRNSNew Project Awards and Operations Update
13th Jul 20223:32 pmRNSResult of Annual Meeting
13th Jun 20227:00 amRNS2021 Annual Report & Notice of 2022 Annual Meeting
17th May 20227:00 amRNSFinal Results for Year Ending 31 December 2021
3rd May 20227:00 amRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSChange of Main Office Address
23rd Mar 20229:17 amRNSTR1
21st Mar 20225:56 pmRNSBroker Option
9th Mar 20207:00 amRNSClosure of Restricted Stock Line
5th Mar 20207:00 amRNSTrading Update
13th Dec 201910:25 amRNSBlock listing Interim Review
4th Nov 20197:00 amRNSTrading Update
16th Sep 20197:00 amRNSHalf Year Results Statement
20th Aug 201912:42 pmRNSHolding(s) in Company
16th Aug 20193:02 pmRNSDirector Shareholding
29th Jul 20197:00 amRNSDirectorate Changes
26th Jul 20197:00 amRNSAppointment of Nominated Adviser & Broker
22nd Jul 20191:34 pmRNSHolding(s) in Company
10th Jul 201912:57 pmRNSResult of Annual Meeting
14th Jun 20197:00 amRNSTrading Update
11th Jun 20197:00 amRNSBlock listing Interim Review
6th Jun 20197:00 amRNSIssue of Equity
31st May 20191:57 pmRNSAnnual Financial Report
13th May 20197:00 amRNSFinal Results for the year ending 31 December 2018
28th Mar 20197:00 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSHolding(s) in Company
27th Sep 20172:44 pmRNSApplication for Block Admission
26th Sep 20175:31 pmRNSClosure of Restricted Stock Line
21st Sep 20177:00 amRNSConsolidation of Stock Lines
13th Sep 20177:00 amRNSHalf Year Results Statement
12th Jul 201712:30 pmRNSResult of Annual Meeting
7th Jul 20177:00 amRNSHalf Year Trading Update
9th Jun 201710:00 amRNSMailing of Annual Financial Report & GM Notice
7th Jun 201710:30 amRNSBlock listing Interim Review
30th May 20171:19 pmRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSContract win with new SABIC affiliate customer
11th May 20177:00 amRNSFinal Results for the year ending 31 December 2016
8th May 20177:00 amRNSContract Award & Notification of Full Year Results
30th Jan 20177:00 amRNSTrading Update
7th Dec 20162:34 pmRNSBlock listing Interim Review
4th Oct 20167:00 amRNSAppointment of Nominated Adviser & Broker
14th Sep 20167:00 amRNSHalf Year Results Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.